CD14 and urinary bladder carcinoma: In contrast, two immunophenotypes were identified as risk factors for bladder cancer: HLA DR on CD14+CD16- monocyte (OR: 1.10, 95% CI 1.03-1.18, p=0.0060) and HLA DR on CD14+ monocyte (OR: 1.11, 95% CI 1.03-1.19, p=0.0048) which are both Monocyte panel.